EMA Application withdrawn: Insulin Human Long Marvel (human insulin) — Marvel LifeSciences Ltd.

View source ↗

Summary

The EMA has withdrawn the application for Insulin Human Long Marvel (human insulin) by Marvel LifeSciences Ltd. for diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Insulin Human Long Marvel (insulin)

Snippet

Status: Application withdrawn. Therapeutic area: Diabetes Mellitus. MAH: Marvel LifeSciences Ltd.. Decision date: 31/12/2009